An experienced biopharmaceutical professional with almost 30 years of industry experience. Proven track record in financings, leading a broad range of transactions, including in- and out-licensing, merger and acquisition, and spin-off transactions to broaden and advance a portfolio of therapeutic/vaccine candidates and enabling technologies. Strong, practical scientific background in drug discovery, product development, and bio manufacturing. An analytical and conceptual thinker skilled in developing strategic, financial, and commercial assessments, and critically negotiating term sheets and contracts for business development transactions. An effective partner across technical and corporate executive teams to stimulate new ideas, review qualitative and quantitative data and drive decision-making.